Zepp Health Corporation (ZEPP) Revenue History
Annual and quarterly revenue from 2015 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2023)
ZEPP's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
By Geography
ZEPP Revenue Analysis (2015–2024)
As of March 1, 2026, Zepp Health Corporation (ZEPP) generated trailing twelve-month (TTM) revenue of $1.68 billion, reflecting explosive growth of +81.3% year-over-year. The most recent quarter (Q3 2025) recorded $539.6 million in revenue, up 26.3% sequentially.
Looking at the longer-term picture, ZEPP's 5-year compound annual growth rate (CAGR) stands at -25.5%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $6.17 billion in 2021.
Revenue diversification analysis shows ZEPP's business is primarily driven by Manufactured Product, Other (74%), and Product (26%). With over half of revenue concentrated in Manufactured Product, Other, the company maintains significant focus in this area while developing other growth vectors.
When compared to Technology sector peers including VUZI (-4.3% YoY), and WLDS (+863.0% YoY), ZEPP has underperformed the peer group in terms of revenue growth. Compare ZEPP vs VUZI →
Peer Comparison
Compare ZEPP's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ZEPPCurrent | $1.7B | +81.3% | -25.5% | -25.9% | |
| VUZI | $6M | -4.3% | -2.9% | -1285.4% | |
| WLDS | $522,000 | +863.0% | +16.6% | -1498.1% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $1.33B | -46.6% | $512.9M | 38.5% | $-345,041,274 | -25.9% |
| 2023 | $2.50B | -40.8% | $653.7M | 26.2% | $-215,522,459 | -8.6% |
| 2022 | $4.22B | -31.7% | $817.2M | 19.4% | $-417,447,389 | -9.9% |
| 2021 | $6.17B | +1.4% | $1.29B | 20.9% | $92.7M | 1.5% |
| 2020 | $6.08B | +4.9% | $1.26B | 20.7% | $164.7M | 2.7% |
| 2019 | $5.80B | +53.0% | $1.46B | 25.3% | $619.0M | 10.7% |
| 2018 | $3.79B | +89.6% | $976.1M | 25.8% | $380.0M | 10.0% |
| 2017 | $2.00B | +22.7% | $482.3M | 24.1% | $177.4M | 8.9% |
| 2016 | $1.63B | +75.9% | $288.9M | 17.7% | $14.0M | 0.9% |
| 2015 | $925.4M | - | $114.2M | 12.3% | $-41,408,376 | -4.5% |
See ZEPP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZEPP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ZEPP vs NVDA
See how ZEPP stacks up against sector leader NVIDIA Corporation.
Start ComparisonFrequently Asked Questions
Is ZEPP's revenue growth accelerating or slowing?
ZEPP revenue is accelerating at +81.3% year-over-year, exceeding the 5-year CAGR of -25.5%. TTM revenue reached $1.7B. Growth momentum has increased versus prior periods.
What is ZEPP's long-term revenue growth rate?
Zepp Health Corporation's 5-year revenue CAGR of -25.5% reflects the sustained expansion pattern. Current YoY growth of +81.3% is above this long-term average.
How is ZEPP's revenue distributed by segment?
ZEPP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2015-2024 are available for download. Segment mix reveals concentration and diversification trends.